H2A.J (H2AJ) is a mammalian-specific histone H2A variant that functions as a core nucleosomal component regulating chr12 structure and gene accessibility. As a direct androgen receptor (AR) target gene, H2AJ plays a critical role in prostate cancer biology by regulating androgen-induced cellular senescence and senescence-associated heterochromatin foci (SAHF) formation 1. H2AJ knockdown inhibits cancer cell growth, while overexpression promotes growth and suppresses mesenchymal markers, suggesting a role in preventing epithelial-mesenchymal transition 1. The gene shows cell-type specific expression, with striking enrichment in luminal epithelial cells of breast, prostate, pancreas, and other glandular tissues, and is highly expressed in luminal carcinoma cell lines 2. In luminal breast cancer cells, H2AJ knockout reduces estrogen-responsive gene expression, implicating it in hormone-driven tumorigenesis 2. Gene profiling studies indicate H2AJ expression correlates inversely or directly with tumor size across different cancer models 3. Overall, H2AJ represents a novel epigenetic regulator linking histone variant biology to cancer cell phenotypes, particularly in luminal epithelial malignancies.